GO:0043652 engulfment of apoptotic cell: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043652 (engulfment of apoptotic cell) describes the phagocytic removal of dying cells by neighboring cells or professional phagocytes.
• This process, also called efferocytosis, prevents secondary necrosis and inflammation and is essential for tissue homeostasis.
• Engulfment requires recognition of eat-me signals such as phosphatidylserine, activation of phagocytic receptors, and cytoskeletal rearrangement.
• Defective clearance of apoptotic cells is linked to autoimmunity, chronic inflammation, atherosclerosis, and cancer progression.
• Key molecular players include MERTK, AXL, TIMD4, MFGE8, GAS6, RAC1, and ELMO1, which coordinate tethering and internalization.
• Experimental models range from Drosophila (engulfment genes in nurse cell death) to mouse macrophages and human cell lines.
Description
The clearance of apoptotic cells by phagocytosis, defined by the Gene Ontology term GO:0043652 (engulfment of apoptotic cell), is a fundamental biological process that maintains tissue homeostasis and resolves inflammation. Every day, billions of cells in multicellular organisms undergo programmed cell death, and their rapid removal by neighboring cells or professional phagocytes prevents the release of toxic intracellular contents that would otherwise trigger inflammation and autoimmunity. This process, often referred to as efferocytosis, is highly conserved from Drosophila to humans and involves a complex interplay of soluble bridging molecules, surface receptors, and intracellular signaling cascades. Researchers study engulfment of apoptotic cell to understand how defects in this process contribute to diseases such as systemic lupus erythematosus, atherosclerosis, and cancer. The efficiency of efferocytosis is now recognized as a key determinant of inflammation resolution and tissue repair, making it an attractive therapeutic target. Moreover, the metabolic reprogramming of macrophages during efferocytosis has emerged as a critical regulator of immune responses. This article provides a comprehensive overview of GO:0043652, covering its definition, molecular mechanisms, key genes, disease associations, and state-of-the-art research methods. By integrating authoritative QuickGO data with real PubMed literature, we aim to equip researchers with a publication-ready resource for studying apoptotic cell clearance.
engulfment of apoptotic cell At A Glance
| GO ID | GO:0043652 |
|---|---|
| GO term | engulfment of apoptotic cell |
| Ontology | biological_process |
| Synonym | engulfment of apoptotic cell corpse; engulfment of cell corpse |
| Major function | Phagocytic removal of apoptotic cells to maintain tissue homeostasis and prevent inflammation |
| Cellular location | Plasma membrane, phagocytic cup, phagosome |
| Key receptors | MERTK, AXL, TIMD4, integrins |
| Bridging molecules | MFGE8, GAS6, Protein S |
| Downstream effectors | RAC1, ELMO1, DOCK180 |
What Is GO:0043652?
GO:0043652 (engulfment of apoptotic cell) is defined as the removal of an apoptotic cell by phagocytosis, either by a neighboring cell or by a professional phagocyte. This biological process encompasses the recognition, tethering, and internalization of apoptotic cell corpses, leading to their degradation within the phagolysosome. It is synonymous with engulfment of apoptotic cell corpse and engulfment of cell corpse.
Why Is engulfment of apoptotic cell Important in Cell Biology?
Engulfment of apoptotic cells is essential for normal development, tissue remodeling, and immune tolerance. Defective clearance leads to secondary necrosis, release of danger-associated molecular patterns, and chronic inflammation, which underlies autoimmune diseases such as lupus and atherosclerosis. Furthermore, efficient efferocytosis actively suppresses inflammation by promoting the secretion of anti-inflammatory cytokines like IL-10 and TGF-beta. In cancer, tumor cells can evade immune surveillance by mimicking apoptotic cells or by altering efferocytosis in the tumor microenvironment. Thus, understanding GO:0043652 has broad implications for immunology, cancer biology, and regenerative medicine.
• Prevents autoimmunity by removing self-antigens before they trigger immune responses.
• Resolves inflammation by promoting anti-inflammatory cytokine secretion and metabolic reprogramming.
• Supports tissue homeostasis and development by clearing dying cells during morphogenesis.
• Dysregulation is linked to atherosclerosis, where defective efferocytosis leads to plaque necrosis.
• In cancer, efferocytosis can suppress anti-tumor immunity and promote tumor progression.
• Neurodegenerative diseases may involve impaired clearance of apoptotic neurons.
• Provides a therapeutic target for chronic inflammatory diseases.
• Serves as a model for studying phagocytosis and cytoskeletal dynamics.
• Metabolic pathways (e.g., glycolysis, fatty acid oxidation) regulate efferocytosis efficiency.
• Drosophila genetics has revealed conserved engulfment genes.
What Happens During engulfment of apoptotic cell?
Recognition and Tethering
In simple terms: The phagocyte first senses and attaches to the dying cell.
Apoptotic cells expose eat-me signals such as phosphatidylserine (PS) on their surface. Soluble bridging molecules like MFGE8, GAS6, and Protein S bind to PS and are recognized by phagocytic receptors including integrins, MERTK, AXL, and TIMD4. This tethering step is reversible and does not require actin polymerization.
Signaling and Engulfment Initiation
In simple terms: The phagocyte receives signals to start engulfing the dying cell.
Ligand binding to receptors activates intracellular signaling pathways, notably the ELMO1-DOCK180-RAC1 module, which promotes actin cytoskeleton rearrangement. RAC1 activation leads to the formation of a phagocytic cup that extends around the apoptotic cell. Other pathways, such as the GULP1 pathway, also contribute to engulfment.
Internalization and Phagosome Maturation
In simple terms: The dying cell is taken inside the phagocyte and digested.
The phagocytic cup closes to form a phagosome, which then fuses with lysosomes to become a phagolysosome. This maturation process requires Rab GTPases and is accompanied by acidification and degradation of the apoptotic cell. The entire process is tightly regulated to avoid release of toxic contents.
Metabolic Reprogramming
In simple terms: The phagocyte changes its metabolism to handle the extra load.
Efferocytosis induces metabolic shifts in macrophages, including increased glycolysis and fatty acid oxidation, which are required for sustained clearance and anti-inflammatory cytokine production. This metabolic reprogramming is regulated by pathways such as mTOR and AMPK.
Anti-inflammatory and Immune Tolerance
In simple terms: The phagocyte sends signals to calm the immune system.
Engulfment of apoptotic cells actively suppresses inflammation by promoting the secretion of IL-10 and TGF-beta and inhibiting pro-inflammatory cytokines. This immunomodulatory effect is crucial for preventing autoimmunity and maintaining tissue homeostasis.
Key Genes Involved in GO:0043652 engulfment of apoptotic cell
The following genes and proteins are central to the recognition, signaling, and execution of apoptotic cell engulfment.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MERTK | Receptor tyrosine kinase that recognizes PS via GAS6/Protein S | Defects linked to autoimmunity and retinal degeneration |
| AXL | Receptor tyrosine kinase involved in PS recognition | Target for cancer immunotherapy |
| TIMD4 | PS receptor on macrophages | Mediates efferocytosis in various tissues |
| MFGE8 | Bridging molecule binding PS and integrins | Knockout mice show impaired clearance |
| GAS6 | Ligand for MERTK/AXL | Regulates efferocytosis and inflammation |
| RAC1 | Small GTPase regulating actin cytoskeleton | Essential for phagocytic cup formation |
| ELMO1 | Adaptor protein activating RAC1 | Required for engulfment in C. elegans and mammals |
| DOCK180 | Guanine nucleotide exchange factor for RAC1 | Works with ELMO1 to promote engulfment |
| GULP1 | Adaptor protein in engulfment signaling | Involved in PS-dependent uptake |
| CRKII | Adaptor protein linking receptors to ELMO1 | Modulates engulfment efficiency |
| ABCA1 | Cholesterol transporter | Affects membrane composition during efferocytosis |
| LC3 | Autophagy protein recruited to phagosomes | Assists in phagosome maturation |
| RAB7 | GTPase regulating phagosome maturation | Required for phagolysosome fusion |
| ATG5 | Autophagy protein involved in LC3 lipidation | Supports efferocytosis in macrophages |
| IL10 | Anti-inflammatory cytokine | Secreted upon efferocytosis |
| TGFB1 | Anti-inflammatory cytokine | Secreted upon efferocytosis |
| PPARG | Nuclear receptor regulating lipid metabolism | Promotes efferocytosis-associated metabolic changes |
| NR1H3 | Liver X receptor | Regulates cholesterol efflux during efferocytosis |
How Is engulfment of apoptotic cell Regulated?
Engulfment of apoptotic cells is regulated at multiple levels. Receptor expression and activity are controlled by transcription factors such as PPARG and NR1H3, which also coordinate lipid metabolism. Metabolic pathways, including glycolysis and fatty acid oxidation, are modulated by mTOR and AMPK signaling to sustain efferocytosis. In addition, inflammatory cytokines can downregulate engulfment receptors, while anti-inflammatory signals upregulate them. The process is also influenced by the availability of bridging molecules and the lipid composition of the phagocyte membrane.
engulfment of apoptotic cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MERTK | Autoimmunity, retinitis pigmentosa | Mertk knockout mouse |
| AXL | Cancer, autoimmune disorders | Axl knockout or overexpression in tumor models |
| MFGE8 | Inflammatory bowel disease, autoimmunity | Mfge8 knockout mouse |
| RAC1 | Developmental defects, immune dysfunction | Conditional Rac1 knockout in macrophages |
| ELMO1 | Inflammatory diseases, cancer | ELMO1 knockout cell lines |
Autoimmune Diseases
Impaired clearance of apoptotic cells leads to the accumulation of self-antigens and triggers autoantibody production, contributing to systemic lupus erythematosus and other autoimmune conditions. Defects in MERTK, GAS6, and MFGE8 have been associated with autoimmunity in mouse models.
Atherosclerosis
In atherosclerotic plaques, defective efferocytosis by macrophages results in secondary necrosis and increased plaque instability. Enhancing efferocytosis is being explored as a therapeutic strategy to resolve inflammation and stabilize plaques.
Cancer
Tumor cells can exploit efferocytosis to suppress anti-tumor immunity. For example, macrophages engulfing apoptotic cancer cells exhibit a pro-inflammatory response that may paradoxically promote tumor growth in some contexts. Targeting efferocytosis receptors like AXL is under investigation for cancer immunotherapy.
Neurodegeneration
Microglial clearance of apoptotic neurons is critical for brain homeostasis. Impaired efferocytosis may contribute to neuroinflammation and neurodegeneration, although direct evidence in human diseases is still emerging.
From engulfment of apoptotic cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate efferocytosis efficiency? | Knockout of gene X in macrophages followed by efferocytosis assay |
| Does a point mutation in gene X affect ligand binding? | Point-mutation knock-in in cell lines |
| Does tagging gene X alter its localization? | Tagged knock-in (e.g., GFP) in phagocytes |
| Does overexpression of gene X enhance clearance? | Overexpression of gene X in cell lines |
| Which genes are essential for engulfment? | CRISPR library screening in phagocytic cells |
| How does gene X affect inflammation resolution? | Knockout mouse models with inflammation challenges |
How to Study the engulfment of apoptotic cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry efferocytosis assay | Percentage of phagocytes with internalized apoptotic cells | Screening for engulfment defects |
| Live-cell imaging | Dynamics of phagocytic cup and phagosome maturation | Visualizing real-time engulfment |
| CRISPR knockout screen | Genes required for efferocytosis | Discovery of novel regulators |
| Metabolomics | Metabolic changes during efferocytosis | Understanding immunometabolism |
| Proteomics | Protein composition of phagosomes | Identifying signaling complexes |
| Drosophila genetics | Conserved engulfment genes | In vivo validation |
| Phosphatidylserine exposure assay | Eat-me signal on apoptotic cells | Characterizing apoptotic cells |
| Cytokine ELISA | Anti-inflammatory cytokine secretion | Measuring resolution of inflammation |
Measuring Efferocytosis Efficiency
Flow cytometry-based assays using fluorescently labeled apoptotic cells are standard for quantifying engulfment. Phagocytosis index and percentage of phagocytes containing apoptotic corpses are common metrics.
Imaging and Live-Cell Analysis
Confocal and time-lapse microscopy allow visualization of phagocytic cup formation, internalization, and phagosome maturation. Fluorescently tagged receptors and apoptotic cells enable dynamic tracking.
Genetic Screens
CRISPR knockout library screens in phagocytic cell lines have identified novel regulators of efferocytosis. Drosophila genetics has also uncovered conserved engulfment genes.
Metabolic and Proteomic Profiling
Seahorse analysis and metabolomics reveal metabolic shifts during efferocytosis. Proteomics of isolated phagosomes can identify recruited proteins.
How CRISPR Can Be Used to Study GO:0043652 engulfment of apoptotic cell
Knockout
CRISPR knockout of candidate genes (e.g., MERTK, RAC1) in macrophage cell lines or primary cells allows assessment of their requirement for efferocytosis. Knockout mice generated via CRISPR can model disease-associated defects.
Point Mutation
Introducing point mutations in engulfment receptors (e.g., MERTK kinase domain) can dissect signaling pathways and mimic human disease variants. CRISPR base editing enables precise nucleotide changes without double-strand breaks.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci allows real-time tracking of receptor localization during engulfment. Knock-in of disease-associated alleles in mice models human conditions.
Overexpression
Overexpression of engulfment genes (e.g., MFGE8, ELMO1) via CRISPR activation or lentiviral delivery can enhance clearance and is being explored therapeutically.
How EDITGENE Supports engulfment of apoptotic cell Research
Researchers studying engulfment of apoptotic cell-related genes often need to determine whether a candidate gene is causally involved in recognition, signaling, or execution of efferocytosis. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for engulfment of apoptotic cell research.
Frequently Asked Questions About engulfment of apoptotic cell
What is engulfment of apoptotic cell (GO:0043652)?
It is the biological process by which apoptotic cells are removed by phagocytosis, either by neighboring cells or professional phagocytes.
What genes are involved in engulfment of apoptotic cell?
Key genes include MERTK, AXL, TIMD4, MFGE8, GAS6, RAC1, ELMO1, and DOCK180.
How is efferocytosis measured?
Common methods include flow cytometry with fluorescently labeled apoptotic cells and live-cell imaging.
What diseases are linked to defective apoptotic cell clearance?
Autoimmune diseases, atherosclerosis, cancer, and neurodegeneration have been associated with impaired efferocytosis.
What is the difference between apoptosis and efferocytosis?
Apoptosis is programmed cell death, while efferocytosis is the phagocytic clearance of apoptotic cells.
Which receptors recognize phosphatidylserine on apoptotic cells?
Receptors such as MERTK, AXL, and TIMD4, often via bridging molecules like GAS6 and MFGE8, recognize phosphatidylserine.
Can CRISPR be used to study engulfment of apoptotic cell?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in efferocytosis.
What is the role of RAC1 in efferocytosis?
RAC1 is a small GTPase that regulates actin cytoskeleton rearrangement necessary for phagocytic cup formation.
How does efferocytosis resolve inflammation?
It promotes secretion of anti-inflammatory cytokines like IL-10 and TGF-beta and reprograms macrophage metabolism.
What model organisms are used to study engulfment of apoptotic cell?
Drosophila, C. elegans, mice, and human cell lines are commonly used.
Conclusion
GO:0043652 (engulfment of apoptotic cell) is a critical biological process that ensures the silent removal of dying cells, thereby maintaining tissue homeostasis and preventing inflammation. The intricate interplay of recognition receptors, bridging molecules, and signaling pathways offers numerous targets for therapeutic intervention in autoimmune diseases, atherosclerosis, and cancer. Advances in CRISPR-based gene editing and screening technologies are accelerating the discovery of novel regulators and the development of efferocytosis-modulating therapies. Continued research into this process promises to yield new insights into immune regulation and tissue repair.
References
- 1. Nagata S. 2018. Apoptosis and Clearance of Apoptotic Cells.. Annu Rev Immunol 36:489-517 PMID: 29400998
- 2. Mehrotra P et al.. 2022. Drugging the efferocytosis process: concepts and opportunities.. Nat Rev Drug Discov 21(8):601-620 PMID: 35650427
- 3. Schilperoort M et al.. 2023. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation.. Immunol Rev 319(1):65-80 PMID: 37158427
- 5. Gage MC. 2019. Measuring Apoptotic Cell Engulfment (Efferocytosis) Efficiency.. Methods Mol Biol 1951:143-152 PMID: 30825150
- 6. Park SY et al.. 2017. Engulfment signals and the phagocytic machinery for apoptotic cell clearance.. Exp Mol Med 49(5):e331 PMID: 28496201
- 7. Mendoza-Reinoso V et al.. 2020. Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance.. Cells 9(2) PMID: 32059476
- 8. Timmons AK et al.. 2017. Control of non-apoptotic nurse cell death by engulfment genes in Drosophila.. Fly (Austin) 11(2):104-111 PMID: 27686122
